Loading…
Legend Biotech Corporation is projected to rise to $32.22 by 2027, a +19% move from its current price of $27.08. LEGN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $26.23 | $27.10 | $28.00 | +0.08% |
| Jul 14 | $25.90 | $27.12 | $28.40 | +0.16% |
| Jul 15 | $25.66 | $27.15 | $28.72 | +0.24% |
| Jul 16 | $25.46 | $27.17 | $28.99 | +0.32% |
| Jul 17 | $25.28 | $27.19 | $29.24 | +0.40% |
| Jul 18 | $25.13 | $27.21 | $29.47 | +0.48% |
| Jul 19 | $24.99 | $27.23 | $29.68 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $24.99 | $27.23 | $29.68 | +0.56% |
| Week 2 | $24.25 | $27.39 | $30.93 | +1.13% |
| Week 3 | $23.73 | $27.54 | $31.96 | +1.70% |
| Week 4 | $23.32 | $27.70 | $32.89 | +2.28% |
| Week 5 | $22.98 | $27.85 | $33.76 | +2.85% |
| Week 6 | $22.69 | $28.01 | $34.58 | +3.43% |
| Week 7 | $22.44 | $28.17 | $35.36 | +4.02% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Legend Biotech Corporation is a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is cilta-cel, a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates and allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting BCMA for MM, which are in investigator-initiated Phase 1 clinical trials in China.
The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein. Legend Biotech was founded in 2014 and is headquartered in Somerset, New Jersey.
Legend Biotech Corporation, LEGN, is currently priced at $27.68 with a market capitalization of $5.35B. It ranks 1335. The 2026 forecast lists an average of $27.68, with a min of $16.65 and a max of $39.60.
Beyond 2026, the forecast projects a rising path with 2027 avg $32.71 and 2028 avg $35.22, and progressively higher figures through 2030 ($38.51) and into 2040 ($96.30) and 2050 ($176.60) as the long-term average, with corresponding max values and upside potential reflected in the forecast up to $362.53.
A major floor 38.0% below — a decisive break under it would weaken the trend.
The nearest floor, 5.8% below — buyers have tended to step in here.
The nearest ceiling, 34.0% above — a clean break opens room to run.
A major ceiling 49.2% above — clearing it would confirm fresh momentum.
Key LEGN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LEGN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $27.61 | Sell | $27.72 | Sell |
| MA 10 | $28.48 | Sell | $28.40 | Sell |
| MA 20 | $30.19 | Sell | $29.23 | Sell |
| MA 50 | $29.40 | Sell | $28.45 | Sell |
| MA 100 | $24.41 | Buy | $26.72 | Buy |
| MA 200 | $25.32 | Buy | $27.11 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.80 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -87.74 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.47 | Sell |
| ROC (12) | -7.58 | Sell |
| Bollinger %B (20,2) | 0.23 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.11 | Sell |
| Awesome (5,34) | -2.95 | Sell |
| Ultimate (7,14,28) | 36.37 | Neutral |
| Momentum (10) | -1.35 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 26.96 | Buy |
| ADX (14) | 15.35 | Neutral |
| ATR (14) | 0.94 | Info |
The 30-day technical picture for LEGN is NEUTRAL, with an RSI14 of 40. The SMA50 sits at $29.18 and the SMA200 at $25.42. Support is at $25.51 and resistance at $36.28, framing a near-term range. The thirty-day range runs from $21.92 to $34.96, and annualized volatility is 70.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.65 | $27.08 | $38.28 | 0% | Neutral | |
| $25.19 | $32.22 | $43.85 | +19% | Neutral | |
| $26.05 | $34.46 | $48.96 | +27% | Bullish | |
| $26.65 | $36.26 | $53.26 | +34% | Bullish | |
| $27.76 | $38.73 | $58.49 | +43% | Bullish | |
| $30.37 | $43.36 | $67.11 | +60% | Bullish | |
| $37.74 | $55.05 | $87.06 | +103% | Bullish | |
| $41.00 | $61.03 | $98.43 | +125% | Bullish | |
| $38.99 | $59.16 | $97.15 | +118% | Bullish | |
| $40.60 | $62.76 | $104.80 | +132% | Bullish | |
| $57.09 | $96.07 | $171.99 | +255% | Bullish | |
| $91.68 | $179.25 | $354.84 | +562% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $16.65 | $27.08 | $32.91 | +0.00% |
| August 2026 | $24.30 | $28.82 | $35.22 | +6.44% |
| September 2026 | $24.36 | $29.14 | $36.07 | +1.09% |
| October 2026 | $23.80 | $28.68 | $35.90 | -1.57% |
| November 2026 | $24.17 | $29.30 | $37.01 | +2.15% |
| December 2026 | $24.64 | $30.05 | $38.28 | +2.55% |
Click any year to see its month-by-month LEGN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, LEGN could reach as high as $38.28, with a base case around $27.08 and support toward $16.65 — roughly 0% from $27.08. A consolidation phase looks the most probable path here.
Expect LEGN to range from $25.19 to $43.85 through 2027. The $32.22 average target implies a +19% move from current prices. That is up +19% on the projected 2026 average. Price action looks broadly range-bound.
The LEGN price prediction for 2028 points to an average of $34.46 (low $26.05, high $48.96) — a potential gain of +27% on today's $27.08. Buyers look set to stay in control over this stretch.
In 2029, LEGN is projected to trade between $26.65 and $53.26, averaging $36.26 — a potential gain of +34% from today's $27.08. That is up +5% on the projected 2028 average. Momentum favours further upside here.
Legend Biotech Corporation's 2030 outlook centres on $38.73, within a $27.76 to $58.49 range. That is up +7% on the projected 2029 average. That marks a +43% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, LEGN could reach as high as $67.11, with a base case around $43.36 and support toward $30.37 — roughly +60% from $27.08. Momentum favours further upside here.
Expect LEGN to range from $37.74 to $87.06 through 2032. The $55.05 average target implies a +103% move from current prices. That is up +27% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The LEGN price prediction for 2033 points to an average of $61.03 (low $41.00, high $98.43) — a potential gain of +125% on today's $27.08. Momentum favours further upside here.
In 2034, LEGN is projected to trade between $38.99 and $97.15, averaging $59.16 — a potential gain of +118% from today's $27.08. That is -3% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
Legend Biotech Corporation's 2035 outlook centres on $62.76, within a $40.60 to $104.80 range. That is up +6% on the projected 2034 average. That marks a +132% change versus current levels. Momentum favours further upside here.
By 2040, LEGN could reach as high as $171.99, with a base case around $96.07 and support toward $57.09 — roughly +255% from $27.08. Buyers look set to stay in control over this stretch.
Expect LEGN to range from $91.68 to $354.84 through 2050. The $179.25 average target implies a +562% move from current prices. That is up +87% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in LEGN today (≈ 36.927622 LEGN) could be worth
$6,619.45
+$5,619.45 (+562%) by 2050 · US Dollar
Based on the average projected LEGN price of $179.25 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LEGNwould be worth at today's price.
$1,000 invested in LEGN on Jul 10, 2025 (≈ 25.182574 LEGN) would be worth
$681.94
-$318.06 (-31.8%) today · 0.68× · US Dollar
Based on a LEGN entry price of $39.71 vs. today's $27.08.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $29.91 | $905.38 | -9.5% |
| 1 month ago | $34.86 | $776.82 | -22.3% |
| 3 months ago | $18.16 | $1,491.19 | +49.1% |
| 6 months ago | $23.7 | $1,142.62 | +14.3% |
| 1 year ago | $39.71 | $681.94 | -31.8% |
| All time (5.0y) ago | $40 | $677 | -32.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LEGN forecast.
Our base-case forecast reaches $54.00 around 2032.
Implied market cap at $54.00: $10.45B
The multi-year outlook shows a bullish trajectory with rising averages and notable upside. In 2026, the forecast lists min $16.65, avg $27.68, max $39.60, with ROI 0 and sentiment NEUTRAL. From 2027 onward, the averages rise to $32.71 (2027), $35.22 (2028), $36.45 (2029), and $38.51 (2030), then accelerate toward $176.60 (2050) as the long-term average, with max values up to $362.53 and ROI reaching 538.
The forecast also shows 2040 with min $54.85, avg $96.30, max $177.85 and ROI 247.9, all labeled BULLISH. These figures should be regarded as estimates, not guarantees, and are subject to uncertainty.
Tap a question to reveal the answer.
2030 min $27.06, avg $38.51, max $59.38, ROI 39.1; sentiment BULLISH.
Forecasts from 2027 onward are labeled BULLISH with rising averages and ROIs, including a 2031 ROI of 57.7 and a 2050 ROI of 538.
The 2030 max is $59.38 and the 2031 max is $69.07, so the forecast allows surpassing $60 in 2031 or later.
Current price is $27.68 and market cap is $5.35B.
2040 min $54.85, avg $96.30, max $177.85, ROI 247.9; sentiment BULLISH.
Legend Biotech Corporation Community Discussion
0Share your Legend Biotech Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.